NCT07049224 The Effectiveness of a Diet With Beef as Key Protein Component Versus a Plant-Based Diet to Support Integrated Muscle Protein Synthesis Rates in Healthy Older Individuals
| NCT ID | NCT07049224 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maastricht University Medical Center |
| Condition | Muscle Protein Synthetic Response to Protein |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-12-09 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-12-09 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Muscles are composed out of proteins. These proteins in turn are composed out of smaller building blocks, called amino acids. By consuming a sufficient amount of dietary protein, a sufficient amount of amino acids become available to build new muscle proteins. The body's ability to build these new muscle proteins is of great importance to maintain muscle strength and function. Previous research suggests that a meal containing proteins from meat results in a better stimulation of the body's ability to build muscle proteins, when compared to a meal containing only plant-based proteins. However, these previous studies have only been performed following the ingestion of a single meal. As a result it is currently unknown how the muscles respond to a more prolonged ingestion of a diet containing animal/meat products, in comparison to a plant-based diet. Therefore, this study aims to investigate how fast new muscle proteins are being build when consuming a diet containing animal/meat products, in comparison to a plant-based (vegan) diet.
Eligibility Criteria
Inclusion Criteria: * Male or female sex * Aged between 65 and 85 y inclusive * BMI between 18.5 and 30 kg/m2 inclusive Exclusion Criteria: * Not willing to consume meat/animal-based products during the study period * Any food allergies (e.g. milk, gluten, etc.) * Participating currently or in the 3 months prior to the study in a structured progressive exercise program. * Smoking * History of cardiovascular, respiratory, gastrointestinal, urogenital, neurological, psychiatric, dermatologic, musculoskeletal, metabolic, endocrine, haematological, immunologic disorders, allergy, major surgery and/or laboratory assessments which might limit participation in or completion of the study protocol, interfere with the execution of the experiment, or potential influence the study outcomes (to be decided by the study team and responsible physician) * Diagnosed with phenylketonuria (PKU) * Donated full blood 3 months prior to test day * Use of any medications that interferes with study participation and/or outcomes (i.e. corticosteroids, non-steroidal anti-inflammatories, gastric acid suppressing medication) as assessed by the study team and responsible medical doctor. * Use of DOAC, vitamin-K-antagonist, or multiple anticoagulants * Fasting blood glucose \>7 mmol/L
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07049224 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 85 Years, studying Muscle Protein Synthetic Response to Protein. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07049224 currently recruiting?
Yes, NCT07049224 is actively recruiting participants. Contact the research team at philippe.pinckaers@maastrichtuniversity.nl for enrollment information.
Where is the NCT07049224 trial being conducted?
This trial is being conducted at Maastricht, Netherlands.
Who is sponsoring the NCT07049224 clinical trial?
NCT07049224 is sponsored by Maastricht University Medical Center. The trial plans to enroll 32 participants.